Status:
COMPLETED
Application of Propofol Mixed With Remifentanil in Fiber Colonoscopyand Analgesia in Fiber Colonoscopy
Lead Sponsor:
Handan First Hospital
Conditions:
Narcotism
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Fiber colonoscopy, as a terminal examination method for lower gastrointestinal diseases, often brings varying degrees of pain, discomfort, tension, and anxiety to patients. Therefore, currently in cli...
Detailed Description
Fibercolonoscopy, as a terminal examination method for lower digestive tract diseases, often brings different degrees of pain and discomfort, tension and anxiety to patients. Therefore, at present, in...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) Grade I - II;
- Age 18-75 years old;
- Body mass index (BMI) \<25㎏/㎡;
- no mental and nervous system diseases;
Exclusion
- Refusal to cooperate or difficulty communicating;
- History of drug allergy;
- Long-term alcoholism and dependence on stabilizing and opioid drugs;
- Patients with past history of intestinal surgery or past difficulty in endoscopic surgery;
- People with hearing impairment
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06175156
Start Date
March 1 2023
End Date
September 1 2023
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Handan First Hospital
Handan, Hebei, China, 056000